HQY icon

HealthEquity

88.83 USD
-0.39
0.44%
At close Mar 27, 4:00 PM EDT
After hours
88.83
+0.00
0.00%
1 day
-0.44%
5 days
6.72%
1 month
-16.98%
3 months
-7.76%
6 months
11.13%
Year to date
-8.24%
1 year
11.43%
5 years
71.12%
10 years
252.36%
0
Funds holding %
of 7,390 funds
0
Analysts bullish %
of 5 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

326% more call options, than puts

Call options by funds: $29.1M | Put options by funds: $6.82M

128.61% more ownership

Funds ownership: 101.56% [Q3] → 230.17% (+128.61%) [Q4]

107% more first-time investments, than exits

New positions opened: 87 | Existing positions closed: 42

50% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 6 (+2) [Q4]

49% more capital invested

Capital invested by funds: $7.27B [Q3] → $10.8B (+$3.55B) [Q4]

17% more repeat investments, than reductions

Existing positions increased: 162 | Existing positions reduced: 139

9% more funds holding

Funds holding: 400 [Q3] → 435 (+35) [Q4]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$94
6%
upside
Avg. target
$111
25%
upside
High target
$125
41%
upside

5 analyst ratings

positive
80%
neutral
20%
negative
0%
Goldman Sachs
David Roman
30% 1-year accuracy
6 / 20 met price target
6%upside
$94
Neutral
Maintained
27 Mar 2025
Raymond James
C. Gregory Peters
87% 1-year accuracy
33 / 38 met price target
29%upside
$115
Strong Buy
Upgraded
25 Mar 2025
Keybanc
Scott Schoenhaus
39% 1-year accuracy
12 / 31 met price target
24%upside
$110
Overweight
Maintained
24 Mar 2025
Barrington Research
Alexander Paris
61% 1-year accuracy
78 / 128 met price target
26%upside
$112
Outperform
Maintained
19 Mar 2025
Wells Fargo
Stan Berenshteyn
22% 1-year accuracy
2 / 9 met price target
41%upside
$125
Overweight
Maintained
26 Feb 2025

Financial journalist opinion

Based on 43 articles about HQY published over the past 30 days

Neutral
Accesswire
8 hours ago
HealthEquity Being Investigated on Behalf of HealthEquity, Inc. Investors. Contact Levi & Korsinsky For Details
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of HealthEquity, Inc. ("HealthEquity") (NASDAQ:HQY) concerning possible violations of federal securities laws. HealthEquity issued a press release on March 18, 2025, announcing its financial results for its fourth quarter and fiscal year ended January 31, 2025.
HealthEquity Being Investigated on Behalf of HealthEquity, Inc. Investors. Contact Levi & Korsinsky For Details
Neutral
Accesswire
8 hours ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc ("HealthEquity" or the "Company") (NASDAQ:HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
Neutral
Accesswire
16 hours ago
HealthEquity, Inc. (HQY) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of HealthEquity, Inc. ("HealthEquity") (NASDAQ:HQY) concerning possible violations of federal securities laws. HealthEquity issued a press release on March 18, 2025, announcing its financial results for its fourth quarter and fiscal year ended January 31, 2025.
HealthEquity, Inc. (HQY) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
Neutral
Accesswire
16 hours ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
NEW YORK CITY, NY / ACCESS Newswire / March 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc ("HealthEquity" or the "Company") (NASDAQ:HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
Neutral
Accesswire
16 hours ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating HealthEquity, Inc. (HQY) And Encourages Investors to Connect
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of HealthEquity, Inc. ("HealthEquity" or "the Company") (NASDAQ:HQY). Investors who purchased HealthEquity securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HQY.
Bronstein, Gewirtz & Grossman, LLC Is Investigating HealthEquity, Inc. (HQY) And Encourages Investors to Connect
Positive
CNBC Television
1 day ago
Trade Tracker: Karen Firestone buys Amgen and buys more HealthEquity
Karen Firestone, executive chairman at Aureus Asset Management, joins CNBC's "Halftime Report" to detail her latest stock purchases. The Investment Committee debate healthcare and biotech companies.
Trade Tracker: Karen Firestone buys Amgen and buys more HealthEquity
Neutral
Accesswire
1 day ago
Levi & Korsinsky Reminds Shareholders of an Investigation into HealthEquity, Inc. (HQY) Regarding Potential Securities Fraud Allegations
NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of HealthEquity, Inc. ("HealthEquity") (NASDAQ:HQY) concerning possible violations of federal securities laws. HealthEquity issued a press release on March 18, 2025, announcing its financial results for its fourth quarter and fiscal year ended January 31, 2025.
Levi & Korsinsky Reminds Shareholders of an Investigation into HealthEquity, Inc. (HQY) Regarding Potential Securities Fraud Allegations
Neutral
Accesswire
1 day ago
Bronstein, Gewirtz & Grossman, LLC Encourages HealthEquity, Inc. (HQY) Stockholders to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of HealthEquity, Inc. ("HealthEquity" or "the Company") (NASDAQ:HQY). Investors who purchased HealthEquity securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HQY.
Bronstein, Gewirtz & Grossman, LLC Encourages HealthEquity, Inc. (HQY) Stockholders to Inquire about Securities Investigation
Neutral
Accesswire
1 day ago
Lost Money on HealthEquity, Inc. (HQY)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of HealthEquity, Inc. ("HealthEquity") (NASDAQ:HQY) concerning possible violations of federal securities laws. HealthEquity issued a press release on March 18, 2025, announcing its financial results for its fourth quarter and fiscal year ended January 31, 2025.
Lost Money on HealthEquity, Inc. (HQY)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
Neutral
GlobeNewsWire
1 day ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
Charts implemented using Lightweight Charts™